Cardia launches worlds first Bio-Container for nutritional supplement and cosmetics market
Cardia is implementing a marketing strategy to launch the Bio-Containers globally. In the first step of this strategy, Cardia is currently working with both a US manufacturer of plastic containers and a major nutritional supplement company to launch the new Bio-Containers into the US market.
Cardia estimates that the packaging (including containers) for this industry alone represents a multi-million dollar business opportunity. This is further supported by "Research and Markets" report on the US Nutritional Supplement industry which is estimated to be worth US$22.5 billion per annum.
Cardia Bioplastics has produced "Bio-Containers" for packaging tablets and cosmetics using its new food contact approved BiohybridTM resins. The Cardia BiohybridTM resins are fully recyclable and comply with the US Food and Drug Administration (FDA) and EU regulatory requirements on materials and articles intended to come into contact with food.
Cardia's Bio-Containers have been independently tested and validated to comply with the stringent performance requirements of the nutritional supplement and cosmetics industries. The Bio-Containers are well-suited to store vitamins, medical tablets, food and nutritional supplements, and cosmetic products. Bio-Containers offer excellent physical properties and shelf life for the stored products. In addition to their excellent performance, Bio-Containers require less oil to produce and have a more favourable environmental profile and carbon footprint than conventional plastic containers.
Cardia BiohybridTM proprietary technology combines renewable thermoplastics with polyolefin material to reduce dependence on finite oil resources and to reduce carbon footprint.
About Cardia Bioplastics
Cardia Bioplastics Limited (ASX CODE: CNN) develops, manufactures and markets its patented renewable resource based materials and finished products derived from Cardia's proprietary technology for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. Established in Australia in 2002 as Biograde, the company Headquarters and Global Applications Development Centre is in Melbourne, Australia. The Product Development Centre and manufacturing plant for resins and finished goods is in Nanjing, China and soon to manufacture under a joint venture for finished goods in Malaysia. There are Cardia Bioplastics offices in the Americas, Australia, Europe and Asia, and a network of leading distributors across the Americas, Asia and Europe. Visit www.cardiabioplastics.com.